Cargando…

Machine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients

Background: Cisplatin is a pivotal drug in the treatment of head and neck cancer, and personalized dosage should help the preservation of an optimal toxicity–efficacy ratio. Methods: We analyzed the exposure-effect relationships of 80 adult patients with head and neck cancers and treated with standa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cauvin, Céleste, Bourguignon, Laurent, Carriat, Laure, Mence, Abel, Ghipponi, Pauline, Salas, Sébastien, Ciccolini, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699030/ https://www.ncbi.nlm.nih.gov/pubmed/36432700 http://dx.doi.org/10.3390/pharmaceutics14112509

Ejemplares similares

Head and neck cancer and asbestos exposure
por: Clin, Bénédicte, et al.
Publicado: (2022)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Role of Tonsillectomy in the Management of Carcinomas of Unknown Primary of the Head and Neck: A Retrospective Study Based on p16 Analysis
por: Podeur, Pauline, et al.
Publicado: (2020)

Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer
por: Shiina, Marisa, et al.
Publicado: (2015)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
por: Brands, Roman C., et al.
Publicado: (2019)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments
por: Marcu, Loredana G.
Publicado: (2013)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
por: Becher, François, et al.
Publicado: (2017)

Mechanistic models for hematological toxicities: Small is beautiful
por: Deyme, Laure, et al.
Publicado: (2021)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Application of radiomics and machine learning in head and neck cancers
por: Peng, Zhouying, et al.
Publicado: (2021)

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
por: Wolff, Hendrik Andreas, et al.
Publicado: (2008)

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
por: Nowicki, PW, et al.
Publicado: (2009)

The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
por: Bostan, Marinela, et al.
Publicado: (2020)

Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis
por: Lee, Jaewang, et al.
Publicado: (2020)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
por: Khamis, Aya, et al.
Publicado: (2022)

Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro
por: Dib, Maria, et al.
Publicado: (2022)

Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion
por: Abdulla, Mohamed, et al.
Publicado: (2023)

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
por: Schneider, Benjamin K., et al.
Publicado: (2019)

Exploring the implications of HPV infection for head and neck cancer
por: Field, Nigel, et al.
Publicado: (2015)

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma
por: Robinson, Anthony M., et al.
Publicado: (2019)

Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells
por: Bourguignon, Lilly Y. W., et al.
Publicado: (2017)

Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
por: Burkitt, Kyunghee, et al.
Publicado: (2008)

Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
por: Cascinu, S., et al.
Publicado: (1994)

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
por: Tahara, Makoto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j9i6cj2aa6urobnnumbk27ctgc